Search Results - "Grechikhina, Maria V"

Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson's Disease with CMV Infection Background by Vavilova, Julia D, Boyko, Anna A, Ponomareva, Natalya V, Fokin, Vitaly F, Fedotova, Ekaterina Y, Streltsova, Maria A, Kust, Sofya A, Grechikhina, Maria V, Bril, Ekaterina V, Zimnyakova, Olga S, Kovalenko, Elena I, Sapozhnikov, Alexander M

“…Immunosenescence is a process of remodeling the immune system under the influence of chronic inflammation during aging. Parkinson's disease (PD) is a common…”
Get full text

Increased Susceptibility of the CD57 - NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response by Palamarchuk, Anastasia I, Alekseeva, Nadezhda A, Streltsova, Maria A, Ustiuzhanina, Maria O, Kobyzeva, Polina A, Kust, Sofya A, Grechikhina, Maria V, Boyko, Anna A, Shustova, Olga A, Sapozhnikov, Alexander M, Kovalenko, Elena I

“…Nowadays, the use of genetically modified NK cells is a promising strategy for cancer immunotherapy. The additional insertion of genes capable of inducing cell…”
Get full text

Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and Lifespan by Streltsova, Maria A, Erokhina, Sofya A, Kanevskiy, Leonid M, Grechikhina, Maria V, Kobyzeva, Polina A, Lee, Dean A, Telford, William G, Sapozhnikov, Alexander M, Kovalenko, Elena I

“…A pattern of natural killer cell (NK cell) heterogeneity determines proliferative and functional responses to activating stimuli in individuals. Obtaining the…”
Get full text

Three-Dimensional Model Analysis Revealed Differential Cytotoxic Effects of the NK-92 Cell Line and Primary NK Cells on Breast and Ovarian Carcinoma Cell Lines Mediated by Variations in Receptor-Ligand Interactions and Soluble Factor Profiles by Alekseeva, Nadezhda A, Boyko, Anna A, Shevchenko, Marina A, Grechikhina, Maria V, Streltsova, Maria A, Alekseeva, Ludmila G, Sapozhnikov, Alexander M, Deyev, Sergey M, Kovalenko, Elena I

“…The functional activity of a certain tumor determines the effectiveness of primary NK cells and NK-92 cell line-based cancer therapy; their therapeutic…”
Get full text

Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair by Alekseeva, Ludmila G, Ovsyanikova, Olga V, Schulga, Alexey A, Grechikhina, Maria V, Shustova, Olga A, Kovalenko, Elena I, Svirshchevskaya, Elena V, Deyev, Sergey M, Sapozhnikov, Alexander M

“…(1) Background: We have previously shown that the use of an artificial supramolecular two-component system based on chimeric recombinant proteins…”
Get full text

Alterations in Proteostasis System Components in Peripheral Blood Mononuclear Cells in Parkinson Disease: Focusing on the HSP70 and p62 Levels by Vavilova, Julia D, Boyko, Anna A, Troyanova, Natalya I, Ponomareva, Natalya V, Fokin, Vitaly F, Fedotova, Ekaterina Y, Streltsova, Maria A, Kust, Sofya A, Grechikhina, Maria V, Shustova, Olga A, Azhikina, Tatyana L, Kovalenko, Elena I, Sapozhnikov, Alexander M

“…Parkinson disease (PD) is attributed to a proteostasis disorder mediated by α-synuclein accumulating in a specific brain region. PD manifestation is often…”
Get full text

HLA‐DR‐expressing NK cells: Effective killers suspected for antigen presentation by Erokhina, Sofya A., Streltsova, Maria A., Kanevskiy, Leonid M., Grechikhina, Maria V., Sapozhnikov, Alexander M., Kovalenko, Elena I.

“…HLA‐DR‐expressing cells comprise an intriguing group of NK cells, which combine phenotypic characteristics of both NK cells and dendritic cells. These cells…”
Get full text

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors by Kalinovsky, Daniel V, Kibardin, Alexey V, Kholodenko, Irina V, Svirshchevskaya, Elena V, Doronin, Igor I, Konovalova, Mariya V, Grechikhina, Maria V, Rozov, Fedor N, Larin, Sergey S, Deyev, Sergey M, Kholodenko, Roman V

“…BackgroundBoth ganglioside GD2-targeted immunotherapy and antibody-drug conjugates (ADCs) have demonstrated clinical success as solid tumor therapies in recent…”
Get full text

ROS production, intracellular HSP70 levels and their relationship in human neutrophils: effects of age by Kovalenko, Elena I, Boyko, Anna A, Semenkov, Victor F, Lutsenko, Gennady V, Grechikhina, Maria V, Kanevskiy, Leonid M, Azhikina, Tatyana L, Telford, William G, Sapozhnikov, Alexander M

“…ROS production and intracellular HSP70 levels were measured in human neutrophils for three age groups: young (20-59 years), elders (60-89 years) and…”
Get full text